Lobbying client
OYE THEREPEUTICS
Pharmaceutical, development stage, company
Filings
24
Filed by
1
Reported in-house
—
Reported by firms
$570,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2021 to 2026
Filings
24 filings, newest first.
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| BELL & LINDSAY, INC. (FORMERLY WHITE HOUSE CONSULTING INC.) | 23 | $570,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 24 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.